about
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objec...
Read More
10.52
-0.23
(-2.14%)
560.5K
XNAS Volume
XNAS 31 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Immunome Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..